Holding(s) in Company (Replacement to 10/04/12)

RNS Number : 3782B

Deltex Medical Group PLC

16 April 2012

 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii			Deltex Medical Group plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments				X
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii		SFM UK Management LLP
4. Full name of shareholder(s)  (if different from 3.):iv		Quantum Partners LP
5. Date of the transaction and date on which the threshold is crossed or reached: v		April 4, 2012
6. Date on which issuer notified:		April 5, 2012
7. Threshold(s) that is/are crossed or reached: vi, vii		3% of the revised shares in issue of 149,767,194

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

N/A

N/A

N/A

N/A

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Contract for Difference

N/A

N/A

N/A

4,900,000

Nominal

Delta

3.27%

3.27%

Total (A+B+C)

Number of voting rights

Percentage of voting rights

4,900,000

3.27%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
This statement relates to a Contract for Difference ("CFD") held for the account of Quantum Partners LP, a Cayman Islands exempted limited partnership ("Quantum Partners"). SFM UK Management LLP, a sub-advisor to Soros Fund Management LLC, serves as investment manager to Quantum Partners and has been granted investment discretion over portfolio investments, including the CFD, held for the account of Quantum Partners.
Proxy Voting:
10. Name of the proxy holder:		N/A
11. Number of voting rights proxy holder will cease to hold:		N/A
12. Date on which proxy holder will cease to hold voting rights:		N/A
13. Additional information:	N/A
14. Contact name:	Jade Cornell Compliance Officer SFM UK Management LLP
15. Contact telephone number:	020 7758 4826

 

END

 

 

HOLVQLBFLZFXBBF